in-Bae7 CD4 Series Open Reagent HIV Rapid Test System Flow Cytometer Machine

Name: in-Bae7 CD4 Series Open Reagent HIV Rapid Test System Flow Cytometer Machine
Brand: ICEN Medical Equipment Limited
SKU: 1947367355

Guangdong, ChinaICEN Medical Equipment Limited

US$30,000.00-40,000.00

1 Piece

Product profile

Customization

Available

Classification

Imaging Diagnostic Equipment

Certification

CE, FDA, EEC, MSDS, ISO13485

Model NO.

IN-BAE7

Laser

488nm Solid

Fluorescence Linearity

≥ 0.99

FSC Sensitivity

≤ 1μm

Detector

FSC,Ssc,FL1-FL5

Test Speed

≥38000 Cells/S

Carry Over

≤ 0.5%

Test Particle Size

0.5-50μm

After-Sale Service

Online Technical Support

Shelf Life

1years

Warranty

1 Year

Material

Metal, Plastic

Transport Package

Carton Package

Trademark

ICEN

Origin

Guangzhou China

Production Capacity

2000 Sets/Month

Company profile

High Repeat Buyers ChoiceMulti-language PioneerIn-stock CapacityFast Delivery

ICEN Medical Equipment Limited

Guangdong, China

Business Type: Manufacturer/FactoryExport Year: 2017-10-01Average Response Time: ≤9.07hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, Others, FCA

AI-Powered supplier vetting

SummaryICEN Technology Company Limited is identified as a China-based manufacturer/factory and limited company, although another record describes it as a trading company. It offers a broad range of medical equipment and reports OEM service for popular brands. The supplier holds ISO 9001 certification, has 6–10 quality-control staff and 6–10 R&D engineers, operates two production lines, and reports lead times within 15 workdays in both peak and off-peak seasons. R&D documentation is available for audit, but no SDK is available and the supplier reports zero R&D patents. It has inventory capacity and provides training, but lacks overseas agents or branches, overseas warehouses, overseas showrooms, and documented manufacturing-capacity contracts with affiliated subcontractors. Financial records are referenced for 2022–2024, but no financial performance details are provided. Customer project experience is described, including hospital design, equipment installation, and after-sales service, but no named customer...

CertificationsThe supplier reports ISO 9001 certification. An audit was conducted by BV, with a report period from 2025-10-23 to 2026-10-22, but the supplied audit result is recorded as 0 and no further interpretation or certification details are provided.

After-Sales capabilityThe supplier states that it provides equipment installation and after-sales service and lists training among its overseas service offerings. However, it has no overseas agents or branches, no overseas warehouse or showroom, and reports service coverage in zero countries, indicating that overseas service infrastructure is limited.

R&D capabilityThe supplier has 6–10 R&D engineers, uses PS and CAD software, operates production-line equipment, and can provide design input, output, review, verification, and validation documentation for audit. However, it reports zero R&D patents and no available SDK, so evidence supports operational R&D capability but not strong proprietary innovation.

Production capacityThe supplier operates two production lines, has 6–10 quality-control staff, reports lead times within 15 workdays during both peak and off-peak periods, and maintains in-stock capacity. Nevertheless, it has no valid manufacturing-capacity contract with affiliated subcontractors, which limits visibility into extended production resources.

Customization capabilityOEM service for popular brands is explicitly reported, and the supplier maintains R&D documentation covering design inputs, outputs, reviews, verification, and validation. These records support customization and product-development coordination, although no specific customized product examples are provided.